Six remarkable and marketable biomedical technologies projects won the semi-finals of the 2018 Jingniuhui·Innovation & Entrepreneurship Competition of the Chinese Academy of Sciences held on Aug 28 at Zhuhai Southern Software Park in Tangjiawan.
The international contest seeks projects with potential to lead the biomedicine industry from R&D institutes, universities and colleges, and enterprises. Numerous applicants were attracted worldwide and screened down to 120 entries.
Award-winning teams in Domestic Group
Nineteen selected projects from Shenzhen, Guangzhou, Foshan, Xi'an, and other Chinese cities competed in the Domestic Group. The Overseas Group had 18 projects from Hong Kong and countries such as the United States and Israel. Their projects, presented at a road session, ranged from non-viral gene vectoring to precision medical treatments.
The top three teams in the respective groups were awarded certificates and are eligible for the final round.
Remarks from Chen Yili, president of the Zhuhai Institute of Advanced Technology, Chinese Academy of Sciences
One of the winning domestic projects involves a platform for animal experiments while an international winner from the US explored the improvement of needleless injections.
The competition is sponsored by the Administrative Committee of the Zhuhai National Hi-tech Industrial Development Zone. The Zhuhai Hi-Tech Innovation & Entrepreneurship Service Center and Zhuhai Institute of Advanced Technology of the Chinese Academy of Sciences are responsible for organization.
Best-performing teams in Overseas Group [Photos courtesy WeChat account of Zhuhai Southern Software Park (ID: chinassp01)]